[ad_1]
Italy
Two cases of variant in Pavia
The San Matteo Polyclinic in Pavia has announced that from the analyzes of its molecular virology laboratories, two cases of Covid have been identified that present the variant discovered for the first time in the United Kingdom. Both patients would have landed in Malpensa in recent days on flights from London. The samples were analyzed by the team led by Professor Fausto Baldanti: “From March until now our laboratory has analyzed, by sequencing, more than 550 viral strains and these are the first cases of the English variant identified ‘.
In Naples, six cases of the Covid variant.
Six cases of the new “English” variant of the coronavirus were also found in Naples. The discovery was made by scientists at Tigem, the Pozzuoli Telethon Institute for Genetics and Medicine. In all six cases, they are people who have recently returned from London and have gone through the Capodichino airport controls. A similar discovery was also made in Veneto, where three patients tested positive for the so-called “English variant”.
“The identification of the six positive cases follows the Region’s ordinance, which blocked flights from the United Kingdom immediately after the news of the discovery of the new variant,” comments the president of the Campania Region Vincenzo De Luca. In addition to the six cases of the new variant, eight other variants of the virus were found in the remaining samples of the study, all of widespread types in Europe.
UK
Trials of a new monoclonal antibody-based coronavirus drug have also started in the UK. A path already followed in the United States by the company Eli Illy, which has obtained a green light from the FDA for minor cases. As reported by the guardian, the drug targeted by researchers at University College London Hospital and AstraZeneca and others 100 Institutes around the world could give immediate immunity, to be assigned to patients already hospitalized or in higher risk categories, infected for no more than eight days.
The research team’s hopes are to show that the antibody mixture can protect against the coronavirus for between six and six years. 12 months. The trial program could end in April with the request for authorization for emergency use. “The advantage of this drug is that it provides you with immediate antibodies – explains Catherine Houlihan, virologist at UCLH -. We could tell trial participants who have been exposed, “yes, you can get the vaccine.” But we could not assure them that it will protect them from the disease, because it is too late: current vaccines do not confer immunity for another month.
France
A new case of the new variant of the Coronavirus discovered in England was discovered in France, in Tours, in a French citizen residing in the United Kingdom. According to the French Ministry of Health, the case is asymptomatic and is now in solitary confinement at home. A similar case has been reported in Japan and in recent days in Germany and Lebanon. France has been recording in the last 24 hours 20,262 new cases, a figure higher than the average also linked to the increase in tests carried out after the Christmas holidays.
Read also:
[ad_2]
